Moulin, Marc
Lewis, Erin D.
Crowley, David C.
Langston, Jamie
Evans, Malkanthi
Funding for this research was provided by:
LifeSeasons, Inc.
Article History
Received: 4 March 2022
Accepted: 5 August 2022
First Online: 22 August 2022
Declarations
:
: J.L. is the Chief Research Officer at LifeSeasons, Inc. M.M., E.L., M.E., D.C., and A.S. have no financial interests in or conflict with the subject matter or materials discussed.
: This study was approved by the Natural Health Product Directorate (NHPD), Health Canada, Ottawa, Ontario on August 26<sup>th</sup>, 2019. Research ethics board approval was granted on August 13<sup>th</sup>, 2019 by the Institutional Review Board IRB Services, Aurora, Ontario. The study was conducted in compliance with the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) Guideline for Good Clinical Practice (GCP) and in accordance with the Declaration of Helsinki guidelines and its subsequent amendments. This study was registered with ClinicalTrials.gov (NCT04093271).
: Informed consent was obtained from all individual participants included in this study.